EUVIMEDEUVIMED entdecken
Crossref

Discovery of natural multi‐targets neuraminidase inhibitor glycosides compounds against influenza A virus through network pharmacology, virtual screening, molecular dynamics simulation, and in vitro experiment

Luxi Cao, Yaru Liu, Bei Ma, Bingxiang Yi, Jiaying Sun

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Luxi Cao und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China. Hauptthemen laut MEDLINE: Influenza A virus, Drugs, Chinese Herbal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza virus continually challenges both human and animal health. Moreover, influenza viruses are easy to mutate. In a certain degree, vaccines may not catch up with rapid mutant paces of viruses. Anti‐influenza drugs NIs (neuraminidase inhibitors) are one of the best choices. Therefore, based on ADMET properties, eight optimal natural multi‐targets NIs glycosides compounds (IC 50 = 0.094–97.275 μM) are found from radix glycyrrhizae, flos sophorae, caulis spatholobi, radix astragali, radix glycyrrhizae, semen astragali complanati , and common fenugreek seed through network pharmacology, molecular docking, dynamics simulation, quantum chemistry, and in vitro experiment. Moreover, mechanism research illustrates these natural compounds treat influenza A virus through key targets TLR4, TNF, and IL6 (high fever, acute respiratory distress syndrome), MAPK1, and MAPK3 (MAPK signaling pathway, viral RNP export, and viral protein expression), IL1B (NOD‐like receptor signaling pathway, suppressed maturation of pro‐IL‐1β and pro‐IL‐18), CASP3 (apoptosis), AKT1 (inhibited premature apoptosis), and EP300 (viral myocarditis, chemoattraction of monocytes and macrophages, T‐cell activation antibody response).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza A virusDrugs, Chinese HerbalAnimalsHumansNeuraminidaseMolecular Dynamics SimulationNetwork PharmacologyMolecular Docking SimulationAntiviral AgentsEnzyme Inhibitors

Stichwörter der Autor:innen

influenzamechanism researchmulti-targetsnetwork pharmacologyneuraminidase inhibitorsvirtual screening

Substanzen

NeuraminidaseAntiviral AgentsEnzyme InhibitorsDrugs, Chinese Herbal

Autor:innen und Institutionen

  • School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China.
  • Key Laboratory of Screening and Activity Evaluation of Targeted Drugs, Chongqing, China.

Zitieren

APA

Cao, L., Liu, Y., Ma, B., Yi, B., & Sun, J. (2024). Discovery of natural multi‐targets neuraminidase inhibitor glycosides compounds against influenza A virus through network pharmacology, virtual screening, molecular dynamics simulation, and in vitro experiment. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14359

Vancouver

Cao L, Liu Y, Ma B, Yi B, Sun J. Discovery of natural multi‐targets neuraminidase inhibitor glycosides compounds against influenza A virus through network pharmacology, virtual screening, molecular dynamics simulation, and in vitro experiment. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14359

BibTeX
@article{Cao2024,
  author = {Cao, Luxi and Liu, Yaru and Ma, Bei and Yi, Bingxiang and Sun, Jiaying},
  title = {Discovery of natural multi‐targets neuraminidase inhibitor glycosides compounds against influenza A virus through network pharmacology, virtual screening, molecular dynamics simulation, and in vitro experiment},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14359}
}
Kostenlos starten →